Escitalopram and Language Intervention for Subacute Aphasia
Status:
Recruiting
Trial end date:
2024-07-18
Target enrollment:
Participant gender:
Summary
In this project, the investigators will investigate the effects of a selective serotonin
reuptake inhibitor (SSRI), escitalopram, on augmenting language therapy effectiveness, as
measured by naming untrained pictures and describing pictures, in individuals with aphasia in
the acute and subacute post stroke period (i.e., within three months post stroke).
Phase:
Phase 2
Details
Lead Sponsor:
Johns Hopkins University
Collaborators:
Medical University of South Carolina University of California, Irvine University of South Carolina